Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells

Toxicology in Vitro

Volumn 29, Issue 3, 2015, Pages 426-437

  Alinovi, Rossella ^a   Goldoni, Matteo ^a   Pinelli, Silvana ^a   Campanini, Marco ^b   Aliatis, Irene ^a   Bersani, Danilo ^a   Lottici, Pier Paolo ^a   Iavicoli, Sergio ^c   Petyx, Marta ^c   Mozzoni, Paola ^a   Mutti, Antonio ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b IMEM CNR   (Italy)

^c DEPARTMENT OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE   (Italy)

Author keywords

Cobalt oxide nanoparticles; Endothelial cells; Inflammation; Oxidative stress; Titanium oxide nanoparticles

Indexed keywords

CHEMOKINE; COBALT NANOPARTICLE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; TITANIUM DIOXIDE NANOPARTICLE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; COBALT; TITANIUM; TITANIUM DIOXIDE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL HETEROGENEITY; CELL VIABILITY; CONCENTRATION (PARAMETERS); CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME SYNTHESIS; HUMAN; HUMAN AORTIC ENDOTHELIAL CELL; HUMAN CELL; INFLAMMATION; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN SECRETION; UMBILICAL VEIN ENDOTHELIAL CELL; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; MITOCHONDRIAL MEMBRANE POTENTIAL; PARTICLE SIZE; PATHOLOGY; THORACIC AORTA;

AORTA, THORACIC; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; COBALT; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; MEMBRANE POTENTIAL, MITOCHONDRIAL; NANOPARTICLES; OXIDATIVE STRESS; PARTICLE SIZE; TITANIUM;

EID: 84920498643     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.12.007     Document Type: Article

References (81)

1. Aird W.C. Phenotypic heterogeneity of the endothelium II. Representative vascular beds. Circ. Res. 2007, 100:174-190.
2. Alarifi S., Ali D., A.O.Suliman Y., et al. Oxidative stress contributes to cobalt oxide nanoparticles-induced cytotoxicity and DNA damage in human hepatocarcinoma cells. Int. J. Nanomed. 2013, 8:189-199.
3. 2 nanocrystals. Appl. Phys. Lett. 1998, 72:73-75.
4. Bhattacharya K., Davoren M., Boertz J., et al. Titanium dioxide nanoparticles induce oxidative stress and DNA-adduct formation but not DNA-breakage in human lung cells. Part Fibre Toxicol. 2009, 6:17.
5. Bihari P., Vippola M., Schultes S., et al. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part Fibre Toxicol. 2008, 5:14.
6. Bisceglie F., Alinovi R., Pinelli S., et al. Ni(II) and Cu(II) N-4-ethylmorpholine citronellalthiosemicarbazonate: a comparative analysis of cytotoxic effects in malignant human cancer cell lines. Metallomics 2013, 5:1510-1518.
7. Borm P.J.A., Schins R.P.F., Albrecht C. Inhaled particles and lung cancer. Part B: Paradigms and risk assessment. Int. J. Cancer 2004, 110:3-14.
8. Borm P.J.A., Robbins D., Haubold S., et al. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol. 2006, 3:11.
9. Businaro R., Tagliani A., Buttari B., et al. Cellular and molecular players in the atherosclerotic plaque progression. Ann. N.Y. Acad. Sci. 2012, 1262:134-141.
10. Byrne J.D., Baugh J.A. The significance of nanoparticles in particle-induced pulmonary fibrosis. McGill J. Med. 2008, 11:43-50.
11. Cai H. Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc. Res. 2005, 68:26-36.
12. Carlson C., Hussain S.M., Schrand A.M., et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J. Phys. Chem. B 2008, 112:13608-13619.
13. Chen R., Huo L., Shi X., et al. Endoplasmic reticulum stress induced by zinc oxide nanoparticles is an earlier biomarker for nanotoxicological evaluation. ACS Nano 2014, 8(3):2562-2574.
14. Chen Z., Wang Y., Ba T., et al. Genotoxic evaluation of titanium dioxide nanoparticles in vivo and in vitro. Toxicol. Lett. 2014, 226:314-319.
15. Chi J.T., Chang H.Y., Haraldsen G., et al. Endothelial cell diversity revealed by global expression profiling. Proc. Natl. Acad. Sci. USA 2003, 100:10623-10628.
16. Choi S.J., Oh J.M., Choy J.H. Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells. J. Inorg. Biochem. 2009, 103:463-471.
17. Christen V., Capelle M., Fent K. Silver nanoparticles induce endoplasmatic reticulum stress response in zebrafish. Toxicol. Appl. Pharmacol. 2013, 272(2):519-528.
18. 2-feasibility and challenges for human health risk assessment based on open literature. Nanotoxicology 2011, 5:110-124.
19. Colognato R., Bonelli A., Ponti J., et al. Comparative genotoxicity of cobalt nanoparticles and ions on human peripheral leukocytes in vitro. Mutagenesis 2008, 23:377-382.
20. Comfort K.K., Braydich-Stolle L.K., Maurer E.I., et al. Less is more: long-term in vitro exposure to low levels of silver nanoparticles provides new insights for nanomaterial evaluation. ACS Nano 2014, 8:3260-3271.
21. Darolles C., Sage N., Armengaud J., et al. In vitro assessment of cobalt oxide particle toxicity: identifying and circumventing interference. Toxicol. In Vitro 2013, 27:1699-1710.
22. De Boeck M., Lombaert N., De Backer S., et al. In vitro genotoxic effects of different combinations of cobalt and metallic carbide particles. Mutagenesis 2003, 18:177-186.
23. Deng D.X., Tsalenko A., Vailaya A., et al. Differences in vascular bed disease susceptibility reflect differences in gene expression response to atherogenic stimuli. Circ. Res. 2006, 98:200-208.
24. Djaoued Y., Badilescu S., Ashrit P.V., et al. Study of anatase to rutile phase transition in nanocrystalline titania films. J. Sol-Gel Sci. Technol. 2002, 24:255-264.
25. Donaldson K., Seaton A. A short history of the toxicology of inhaled particles. Part Fibre Toxicol. 2012, 9:13.
26. Donaldson K., Duffin R., Langrish J.P., et al. Nanoparticles and the cardiovascular system: a critical review. Nanomedicine 2013, 8:403-423.
27. Duffin R., Tran L., Brown D., et al. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal. Toxicol. 2007, 19:849-856.
28. EPA, U.S., 2007. EPA Nanotechnology White Paper U.S. Environmental Protection Agency, Washington, USA.
29. EPA, U.S., 2009. Office of Research and Development. Final Nanomaterial Research Strategy (NRS). U.S. Environmental Protection Agency, Washington, USA.
30. Gojova A., Guo B., Kota R.S., et al. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ. Health Perspect. 2007, 115:403-409.
31. Han X., Gelein R., Corson N., et al. Validation of an LDH assay for assessing nanoparticle toxicity. Toxicology 2011, 287:99-104.
32. Han S.G., Newsome B., Hennig B. Titanium dioxide nanoparticles increase inflammatory responses in vascular endothelial cells. Toxicology 2013, 306:1-8.
33. Hendren C.O., Mesnard X., Droge J., et al. Estimating production data for five engineered nanomaterials as a basis for exposure assessment. Environ. Sci. Technol. 2011, 45:2562-2569.
34. Horev-Azaria L., Kirkpatrick C.J., Korenstein R., et al. Predictive toxicology of cobalt nanoparticles and ions: comparative in vitro study of different cellular models using methods of knowledge discovery from data. Toxicol. Sci. 2011, 122:489-501.
35. Iavicoli S., Rondinone B.M., Boccuni F. Occupational safety and health's role in sustainable, responsible nanotechnology: gaps and needs. Hum. Exp. Toxicol. 2009, 28:433-443.
36. Iavicoli I., Leso V., Fontana L., et al. Toxicological effects of titanium dioxide nanoparticles: a review of in vitro mammalian studies. Eur. Rev. Med. Pharmacol. Sci. 2011, 15:481-508.
37. Iavicoli I., Leso V., Bergamaschi A. Toxicological effects of titanium dioxide nanoparticles: a review of in vivo studies. J. Nanomaterials 2012, 2012:964381.
38. Jeng H.A., Swanson J. Toxicity of metal oxide nanoparticles in mammalian cells. J. Environ. Sci. Health A-Tox. Hazard. Subst. Environ. Eng. 2006, 41:2699-2711.
39. 2 particulates: the contribution of physicochemical characteristics. Part Fibre Toxicol. 2009, 6:33.
40. Jugan M.L., Barillet S., Simon-Deckers A., et al. Titanium dioxide nanoparticles exhibit genotoxicity and impair DNA repair activity in A549 cells. Nanotoxicology 2012, 6:501-513.
41. Karlsson H.L., Cronholm P., Gustafsson J., et al. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem. Res. Toxicol. 2008, 21:1726-1732.
42. Kenzaoui B.H., Bernasconi C.C., Guney-Ayra S., et al. Induction of oxidative stress, lysosome activation and autophagy by nanoparticles in human brain-derived endothelial cells. Biochem. J. 2012, 441:813-821.
43. Kreyling W.G., Semmler M., Erbe F., et al. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J. Toxicol. Environ. Health A 2002, 65:1513-1530.
44. Landsiedel R., Ma-Hock L., Kroll A., et al. Testing metal-oxide nanomaterials for human safety. Adv. Mater. 2010, 22:2601-2627.
45. Landsiedel R., Fabian E., Ma-Hock L., et al. Toxico-/biokinetics of nanomaterials. Arch. Toxicol. 2012, 86:1021-1060.
46. Liu S.C., Xu L.J., Zhang T., et al. Oxidative stress and apoptosis induced by nanosized titanium dioxide in PC12 cells. Toxicology 2010, 267:172-177.
47. Love S.A., Maurer-Jones M.A., Thompson J.W., et al. Assessing nanoparticle toxicity. Ann. Rev. Anal. Chem. 2012, 55:181-205.
48. Lundqvist M., Stigler J., Elia G., et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. USA 2008, 105:14265-14270.
49. Lynch I., Cedervall T., Lundqvist M., et al. The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv. Colloid Interface Sci. 2007, 134-35:167-174.
50. McCall M.N., Kent O.A., Yu J.S., et al. MicroRNA profiling of diverse endothelial cell types. BMC Med. Genomics 2011, 4:78.
51. Moller P., Jacobsen N.R., Folkmann J.K., et al. Role of oxidative damage in toxicity of particulates. Free Radical Res. 2010, 44:1-46.
52. Monopoli M.P., Pitek A.S., Lynch I., et al. Formation and characterization of the nanoparticle-protein corona. Nanomater. Interfaces Biol.: Methods Protocols 2013, 1025:137-155.
53. Monteiro-Riviere N.A., Inman A.O., Zhang L.W. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol. Appl. Pharmacol. 2009, 234:222-235.
54. 2 nanoparticles induce dysfunction and activation of human endothelial cells. Chem. Res. Toxicol. 2012, 25:920-930.
55. 2 in human alveolar epithelial cells. Toxicol. Lett. 2013, 222:102-116.
56. Nemmar A., Hoet P.H.M., Thomeer M., et al. Passage of inhaled particles into the blood circulation in humans - response. Circulation 2002, 106:E141-E142.
57. Nguyen V., Hanna G., Rodrigues N., et al. Differential proteomic analysis of lymphatic, venous, and arterial endothelial cells extracted from bovine mesenteric vessels. Proteomics 2010, 10:1658-1672.
58. NIOSH, 2011. Current Intelligence Bulletin 63: Occupational Exposure to Titanium Dioxide. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Atlanta, USA.
59. Oberdorster G., Oberdorster E., Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113:823-839.
60. Ortega R., Bresson C., Darolles C., et al. Low-solubility particles and a Trojan-horse type mechanism of toxicity: the case of cobalt oxide on human lung cells. Part Fibre Toxicol. 2014, 11:14.
61. Papis E., Rossi F., Raspanti M., et al. Engineered cobalt oxide nanoparticles readily enter cells. Toxicol. Lett. 2009, 189:253-259.
62. Peters K., Unger R.E., Kirkpatrick C.J., et al. Effects of nano-scaled particles on endothelial cell function in vitro: studies on viability, proliferation and inflammation. J. Mater. Sci.-Mater. Med. 2004, 15:321-325.
63. 2 nanoparticles in human hepatoma HepG2 cells. Nanotoxicology 2011, 5:341-353.
64. Prasad R.Y., Wallace K., Daniel K.M., et al. Effect of treatment media on the agglomeration of titanium dioxide nanoparticles: impact on genotoxicity, cellular interaction, and cell cycle. ACS Nano 2013, 7:1929-1942.
65. Prasad R.Y., Simmons S.O., Killius M.G., et al. Cellular interactions and biological responses to titanium dioxide nanoparticles in HepG2 and BEAS-2B cells: role of cell culture media. Environ. Mol. Mutagen. 2014, 55:336-342.
66. Pujalte I., Passagne I., Brouillaud B., et al. Cytotoxicity and oxidative stress induced by different metallic nanoparticles on human kidney cells. Part Fibre Toxicol. 2011, 8:10.
67. 2 production as a basis for exposure assessment. Environ. Sci. Technol. 2009, 43:4227-4233.
68. Schulte P.A., Salamanca-Buentello F. Ethical and scientific issues of nanotechnology in the workplace. Environ. Health Perspect. 2007, 115:5-12.
69. Skocaj M., Filipic M., Petkovic J., et al. Titanium dioxide in our everyday life; is it safe?. Radiol. Oncol. 2011, 45:227-247.
70. Soto K., Garza K.M., Murr L.E. Cytotoxic effects of aggregated nanomaterials. Acta Biomater. 2007, 3:351-358.
71. Strobel C., Torrano A., Herrman R., et al. Effects of the physicochemical properties of titanium dioxide nanoparticles, commonly used as sun protection agents, on microvascular endothelial cells. J. Nanoparticles Res. 2014, 16:2130.
72. Szasz T., Thakali K., Fink G.D., et al. A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease. Exp. Biol. Med. 2007, 232:27-37.
73. Tsai Y.Y., Huang Y.H., Chao Y.L., et al. Identification of the nanogold particle-induced endoplasmic reticulum stress by omic techniques and system biology analysis. ACS Nano 2011, 5:9354-9369.
74. 2 nanoparticles, a common component of sunscreens and cosmetics, on human keratinocytes. Cell Death Dis. 2013, 4:e549.
75. 2. Protoplasma 2012, 249:493-502.
76. Vandesompele J., De Preter K., Pattyn F., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3. research0034.
77. Wang W.M., Deng M.J., Liu X.T., et al. TLR4 activation induces nontolerant inflammatory response in endothelial cells. Inflammation 2011, 34:509-518.
78. Weir A., Westerhoff P., Fabricius L., et al. Titanium dioxide nanoparticles in food and personal care products. Environ. Sci. Technol. 2012, 46:2242-2250.
79. Xia T., Li N., Nel A.E. Potential health impact of nanoparticles. Annu. Rev. Public Health 2009, 30:137-150.
80. Zhang R., Piao M.J., Kim K.C., et al. Endoplasmic reticulum stress is involved in silver nanoparticles-induced apoptosis. Int. J. Biochem. Cell Biol. 2012, 44:224-232.
81. 2 nanoparticles in cells by flow cytometry. Cytometry A 2010, 77A:677-685.